In a letter to the DEA, ASHP and its partners pointed out that pharmacists in five states — Colorado, Iowa, Nevada, North Dakota and Oregon — are authorized to prescribe controlled substances but are not listed on the DEA’s “Mid-Level Practitioners Authorization by State ” table.
The omission prevents pharmacists from obtaining DEA registration, limiting their ability to prescribe medications, including those for opioid use disorder, according to a March 4 ASHP news release.
The organization is urging the DEA to update its policies to remove the barriers that prevent pharmacists from fully utilizing prescriptive authority.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.